Ovarian hyperstimulation syndrome followed by ovarian torsion in premenopausal patient using adjuvant tamoxifen treatment for breast cancer
Tamoxifen is a popular medication used in the adjuvant therapy of hormone sensitive breast cancer. In this case report we describe a 39 years old woman presented with ovarian hyperstimulation on the underlying thamoxifen treatment and consecutive ovarian torsion.
Main Authors: | Behnaz Moradi, Mohammad Ali Kazemi, Maryam Rahamni, Masoumeh Gity |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2016-09-01
|
Series: | Asian Pacific Journal of Reproduction |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2305050016301099 |
Similar Items
-
Spontaneous Ovarian Hyperstimulation Syndrome: Looking Beyond the Ovary
by: Sukhpreet Patel, et al.
Published: (2020-09-01) -
A rare presentation of endogenous human chorionic gonadotrophin associated severe ovarian hyperstimulation in the second trimester: a case report
by: Abraham Fessehaye, et al.
Published: (2021-07-01) -
Laparoscopic detorsion for bilateral ovarian torsion in a singleton pregnancy with spontaneous ovarian hyperstimulation syndrome
by: Sujal Munshi, et al.
Published: (2014-01-01) -
Antral follicle count and anti-Müllerian hormone level as predictors of ovarian hyperstimulation syndrome in women with polycystic ovarian syndrome undergoing controlled ovarian stimulation
by: Izhar Rubina, et al.
Published: (2021-08-01) -
Ovarian hyperstimulation closely associated with resumption of follicular growth after chemotherapy during tamoxifen treatment in premenopausal women with breast cancer: a multicenter retrospective cohort study
by: Rena Yamazaki, et al.
Published: (2020-01-01)